D uring the past decade, many large firms implemented managed care programs to provide health care benefits for their employees. The trend toward managed care continue s and is rapidly becoming the industry standard . This trend creates challenges to maintain reasonable access to services and to monitor clinical outcomes associated with new treatment paradigms evolving as a result of managed care.
Mental health and substance abuse disorders tend to be the fastest growing component of the health care premium (Frank, 1991) . Unfortunately, treatment plan efficiencies of prepaid health policies may be at odds with the short term and long term clinical benefits for consumers. Mechanic (1995) found the costs for treating mental health and substance abuse issues have been increasing, outpacing the growth in other areas. Their concern was while managed care is a strategy which may increase availability of treatment, contain costs, and increase quality, it could result in the denial of needed treatments, reduction in quality of service, and a cost shifting to clients, professionals, and the community. Seltzer (1988) noted a trend in managed care to rule out treatment of chronic problems (defined as problem s not treatable in 30 hospital days or 20 outpatient visits). These limitations could actually increase the extent of a chronic illness such as substance abuse. This, in tum, could increase the cost to the individual and society, as well as adversely affecting the outcome to the client.
The problem and the challenge for managed substance abuse care is to be able to restrict and limit unnecessary health care use and, at the same time, not withhold needed and efficient services. Further, this process must be cost effective, services must remain accessible , and the fiscal aspects must be manageable . All of this must be accomplished without compromising the quality of care or reducing outcome efficacy.
This article reviews currently available literature related to the issues of access and outcome and demonstrates the need for additional focused studies on this issue. In addition, carving out substance abuse benefits from health plans and the use of employee assistance programs (EAPs) as they relate to access and outcome are described.
BACKGROUND
In its seventh special report to the U.S. Congress, the U.S. Department of Health and Human Services (1990) reported that the cost of alcohol abuse and dependence was projected to increase from $116.9 billion in 1983 to $150 billion in 1995. Of the $116.9 billion cost in 1983, approximately $71 billion (61%) was attributed to lost employment and reduced productivity, with $15 billion (13%) to health care costs and treatment. Roman (1988) noted that little quantifiable information was available about the impact of substance abuse problems on issues such as absenteeism, tardiness, accidents, and other production related problems . Muldoon (1980) found, in a cost analyses of 104 employees who underwent treatment for alcohol abuse, a 48% reduction in lost work days, a 27% decrease in workers ' compensation claims, and an overall 64% reduction in the amount paid for these claims. Conversely, an analyses of 48 employees who did not undergo treatment demonstrated a 121% increase in the number of lost work days, a 25% increase in the number of workers' compensation claims, and a 77% increase in the amount paid for these claims.
To appreciate the problems and barriers relating to substance abuse and managed care, an understanding of the fundamental concepts of managed care is required. Langwell (1991) defined managed care as a system which involves a variety of interventions in the delivery and financing of health care. These interventions involve review of decisions about services to be provided, limitation or influencing of provider choices, and negotiation of fees. Garnick (1994) described four types of managed care programs:
Case management coordinates health care and other service needs for the client enrolled in a particular plan. Typically, the case manager deals with clients experiencing more complex disorders. While there do not appear to be any standards relative to the qualifications of a case manager, Tilcher (1990) found the that personnel trained in mental health or substance abuse issues were more likely than those without training to ask relevant questions. Training increased the case managers' ability to have more meaningful dialogue with providers and to be more assertive regarding treatment alternatives. This, in tum, strengthened the efficacy of a treatment plan for any client, while reducing any potential negative impact managed care might create for an individual. Garnick (1994) and Woodward (1992) found a lack of explicit criteria for case managers. Woodward believed goals of case management differ from those of managed care. Whereas case management is concerned with providing coordinated care, services, and client advocacy, managed care is focused on cost control, theoretically without compromising quality of care. Case managers have two roles: one as a gatekeeper and the other as a service broker. These roles appear to be in conflict, as a gatekeeper prevents expensive care not approved by the carrier, regardless of client need. Approved services are brokered in an effort to use less expensive care which is presumed to be as effective. This function is expected to have an impact on access and may affect treatment outcome.
The American Psychological Association has called for a federal prohibition of third party review or utilization management because of this conflict of interest (Hodgkin, 1992) . However, cautioned against this approach. He believed regulation would raise the cost of utilization management, resulting in a shift to other cost management strategies, such as benefit cutbacks. Docherty (1990) demonstrated when symptom relief was the sole criteria employed by utilization management for discharge, the discharges tended to be premature. Findings showed utilization management insisted on discharge, arguing that the client could be treated in a less restrictive and less expensive setting even if these services were not available in the area.
Preadmission certification is a process by which the health care carrier reviews a client's needs for hospitalization prior to admission. If the reviewer believes the admission is inappropriate or more cost effective means exist to treat the person, the admission would not be authorized by the carrier and therefore not covered. Clinical criteria are used to determine whether a particular admission is justified. Several organizations sell criteria for use by any carrier. The use of "canned" criteria may depersonalize the evaluation of an individual client's needs. The literature is not clear about whether the use of this form of criteria could account for the variables which need to be met for each individual, as well as the vast array of services and providers available. These systems need to be studied to assure that the use of "logical" criteria software is capable of meeting any illogical needs of the client. However, it is important to note no documented cases found by suggested precertification programs jeopardized client safety.
Managed care providers typically do not reveal the criteria used for determining which health care services are appropriate for individual situations. A review of the literature demonstrates admissions criteria are currently a function of the health care carrier. Many of these carriers regard their criteria as proprietary and will not relinquish them for analysis or critique. found the carriers fear once the criteria are known, providers would mold client histories to match the relevant criteria. Limited availability to the clinical criteria in use for evaluating admission appropriateness and lack of existing standards make the evaluation of access, process, and outcome a difficult task.
Concurrent review is a method by which a client's progress is monitored after admission. This process allows the carrier to either authorize additional inpatient days or discontinue approval for admission. England (1991) found 80% of admissions of private psychiatric hospitals surveyed required precertification and 75% required concurrent review. Dickey (1992) found limited support for concurrent review over preadmission certification as a methodology for managing mental health issues. They reviewed the experience of two companies with 20,000 employees or more each, and compared concurrent review to precertification. Over a 2 year period, length of stay increases were 6.87% (17.3 to 24.17 days) for concurrent review and 13.07% (10.2 to 23.27 days) with precertification. Annual bed days rose 4.39% (25.04 to 29.43 days) with concurrent review and 14.58% (12.05 to 26.63 days) with prior approval. These data were obtained using a multivariate analysis adjusting for case mix and hospital characteristics. The increases could be expected because of the hypothetical expectation that managed care becomes involved in more complex cases. This would lead to an increase in admissions with major mental illnesses or an increase in comorbidity (defined as a psychiatric illness with substance abuse as a secondary diagnoses). Under managed care, these numbers were expected to plateau and begin to decline. Unfortunately, this study did not continue long enough to measure that expectation. The study was limited because only two companies were analyzed and their experience may not be representative of overall use patterns.
Outpatient review is similar to concurrent review in that the process allows the carrier to monitor a client's progress and control authorization for continuation of services. This has been particularly distressing to the therapeutic community as practitioners are being asked to shorten treatment plans contrary to their therapeutic experience. Outpatient review becomes extremely important if the majority of care is going to be delivered on an outpatient basis. Any system designed to fund services for substance abuse must complement, not interfere, with clinical science (Arons, 1994) .
ACCESS
Access can be defined most simply as the ability of clients to enter a treatment program clinically appropriate for their needs. This definition needs to be broadened so it also encompasses a client's ability to see the program through completion, in addition to admission. Gould (1992) examined the effects of managed care on mental health and substance abuse issues in Virginia. In this study, 6,748 surveys were sent to private sector agencies and professionals, with 10.7% responding. The findings indicated mental health and substance abuse needs and services in the private sector exceeded insurance reimbursements and copayments. This study also looked at data specific to 2,000 clients of which 63% sought treatment for mental health problems, 21% for substance abuse, and 15% had illnesses dealing with both issues. The researchers found that, of clients seeking substance abuse services from community sources, 11% did not have the services available to them under managed care. In addition, 28% could not access services because of non-negotiable copayment issues. When they examined aggregate annualized data, the researchers found 71,000 Virginia citizens were adversely affected by managed care and, of these, 29.44% were mental health/substance abuse clients.
The Virginia study (Gould, 1992) was retrospective in design and analyzed data from a 3 month period only. While the findings were annualized, it would have been beneficial to gather these data over a more extended time period. Further, the study does not indicate how long the managed care philosophy had been in place. Therefore, it cannot be determined if the findings were a reaction to change or indeed reflected a trend and its scope. Callahan (1995) studied Massachusett's first year experience with a managed Medicaid program for mental health and substance abuse issues. They found the demand for outpatient services rose by 10.6% and admissions fell by 7.2%. Further, lengths of stays dropped by 12.3%. The rise in demand for outpatient services was a result of fewer admissions and reduced lengths of stay. The study found, in the opinion of providers, no change in access since the implementation of managed care. The providers were asked to rate access on a Likert scale of 1 to 5 (better to worse). The average score was 3.02. Unfortunately, a survey of client perceptions was not conducted.
The number of clients using mental health/substance abuse benefits rose slightly in the year of the study (Callahan, 1995) , from 21.27% to 22.26%. The number ofinpatient hospital services fell while access to freestanding detoxification, acute residential substance abuse facilities, methadone treatment, clinic treatment and consultation, SEPTEMBER 1997, VOL. 45, NO.9 and psychiatric day treatment increased. One interesting finding of this study was that access for disabled clients rose while access for non-disabled clients decreased. (Disabled clients were defined as those receiving supplemental security income and health care assistance only, whereas the non-disabled group were primarily those individuals receiving aid to families with dependent children.) The researchers could not identify why this occurred. This study only reflects 1 year of history, focusing more on cost issues. Expanding the study to encompass a longer time period to determine if the results represent a long term trend is needed. In addition to cost issues, a clinical outcome analyses would be beneficial.
Clients with substance abuse may not have as effective outcomes under managed care programs (Woodward, 1992) . This may be due to the greater scrutiny implicit in managed care which may increase an individual's hesitancy to seek or continue treatment. Gould (1992) reported a shift of services from 44% to 60% for outpatient care. Ofthe clients observed, 30% experienced capped services, requiring them to seek charitable care. Twenty percent could not afford the copayments required under their health plan. A total of 12% found that services were not available under managed care. Of the 58% of clients needing additional short term treatment, 29% received less intensive programs than recommended for their mental health conditions. Although these findings could result in a higher drop out ratio of clients, this measure was not quantified in this study. Hillman (1989) demonstrated that financial incentives to managed care physicians, as well as the type of HMO, influences physician behavior. The study surveyed 595 HMOs in operation in 1987. Researchers examined the relationship between financial incentives and the use of resources, measured by the rate of hospitalization and the rate of outpatient visits. For example, the use of salary based payment rather than fee for service yielded a reduction of 13.1% hospital days, with outpatient visits increasing by 10%. On the other hand, capitation reduced the number of hospital days by only 6%. The study also found that some HMOs would not renew physicians' contracts if their treatment practices were inconsistent with the financial goals of the organization. This evidence suggests managed care may have unintended and undesirable effects on a health care provider's behavior. This study focused on overall practice behaviors. It is inferred that this trend of practice behavioral patterns can be applied to the mental health and substance abuse area.
Some providers no longer communicate with certain managed care systems because of repeated denials for treatment, regardless of client needs. While these providers do not tum the client away, they cannot recommend or help the individual access the specific care they require. Unfortunately, as demonstrated by Gould (1992) , these clients are either guided into a less effective system or out of the system entirely. In fact, Docherty (1990) surveyed members of the National Association of Private Psychiatric Hospitals and found that 50% of the respondents had clients sign out against health care advice. The clients discontinued care because they were informed by their man-aged care plan that treatment would not be covered, even though the clinician affirmed the necessity.
Managed care arrangements may actually discourage individuals from entering treatment (Walsh, 1985) . Group modalities rather than private treatment very well may threaten client privacy choices. Clients' social contacts may learn about their treatment, as well as details shared in a group setting. For some individuals this concern about lack of privacy eliminates group treatment and access to system services as an option. Finch (1992) found that the probability of admission for those enrolled in a managed care program was only 48% as high as those enrolled in a fee for service plan. This difference reflects the use of services by those individuals with dual diagnosis of a mental health disorder as well as substance abuse. The study was not specifically designed to look at substance abuse of the overall population; rather, it examined substance abuse treatment of the chronically mentally ill. Because of the restrictiveness of the study design, generalizations cannot be made to the overall population. However, questions for future studies can be developed that could be generalized to a broader population:
• What happens to those clients who, under managed care, are not admitted to treatment? • Are they shifted to outpatient care?
• If so, how many accept that or withdraw from attempts to enter treatment? Managed care plans tend to be structured to offer the most comprehensive coverage for mental health and substance abuse for situations involving relatively low levels of financial risk. Arons (1994) found that services used to treat the more severe forms of these illnesses were usually lacking in managed care plans. Insurance coverages typically provide for a predetermined number of outpatient visits or inpatient days. Extended hospital stays or day treatment and rehabilitative services are either not covered or extremely restricted. This implies that managed care programs control financial risks by providing a focus on short term treatment without recognition of the more serious illnesses. The presumption that limited coverages for treatment of mental health and substance abuse disorders are sufficient presents a fundamental flaw in health care delivery philosophy. Simply limiting services is an insufficient means of managing costs: "Persons who receive inadequate or no care do not disappear" (Gould, 1992) .
When a client reaches benefit limits, payment comes from personal funds, if available, or treatment is sought from a publicly supported provider. If the client lacks funds or is unfamiliar with the public sector system, access to care is lost. Gould (1992) demonstrated that treatment needs exceeded insurance provisions. This, in tum, effectively strained the public sector system, requiring the development of new systems to compensate for the shortcomings of private managed care. Interestingly, systems in the public sector are following a managed care model, presumably for cost reasons. While many states have implemented these designs, data are only now available which enable an analysis of these systems.
OUTCOMES
The apparent goal of managed care is to reduce costs by fee negotiation, as well as reducing treatment units by restricting access. The managed care system implies that the use of more efficient treatment paradigms will not adversely impact outcome. Seltzer (1988) theorized that limitations imposed by managed care could actually increase the extent of chronic illness, ultimately costing the individual and the health care system more, for example, expanding overall costs by increasing copayments and the expansion of cost shifting philosophies. found relatively few studies regarding client outcomes as opposed to cost and utilization outcomes. This mayor may not be the result of the relative newness of the managed care concept and the consequent data shortage.
Available studies are either cross sectional or short term longitudinal designs. While this type of study design may yield trend data, it cannot be considered conclusive. Managed care is changing so rapidly that developing longer term prospective studies would be difficult. However, further studies are imperative to obtain validation that the new paradigms meet a quality standard.
Cutting costs by restricting access to services may lead to a higher incidence of recidivism (Frabotta, 1989) . This also may hold true for managed care plans substituting outpatient care for inpatient services. Client outcome studies generally look at recidivism as a means of evaluating program efficacy. Readmission rates are measured at time intervals predetermined by each project. Issues such as social function, criminal justice, client satisfaction, public safety, and overall impact in other health care areas are not examined by researchers in a regular or standard fashion with regard to the impact of managed care.
In the Massachusetts Medicaid study, Callahan (1995) found 30 day readmission rates dropped slightly from 19.9% to 18.9% after the implementation of managed care. This report did not reflect whether or not the 1% drop was statistically significant. The study also only looked at data from the first year's experience. An anecdotal finding of this study was that when readmission rates were split to a non-disabled and disabled group, the disabled group had a decline in readmission from 25.8% to 22.7%. The non-disabled rate of readmission rose 11.1% to 13.4%. The authors could not explain that finding. Renz (1995) analyzed the effect of managed care on treatment outcomes for substance abuse disorders at a single treatment facility. The outcome measure examined the rate of client return for treatment at a level of care equal to or higher than their discharge level. The retrospective study covering a 2 year period reviewed 1,594 records of adult clients admitted for substance use disorders. The researchers found that while there was no difference in recidivism by groups based on age, gender, or marital status, there was a significant difference related to ethnicity.
The study (Renz, 1995) also examined four funding plans for the treatment of substance abuse. These were: • Intensive managed care. • Traditional managed care. • Private pay. • State funded.
No significant difference in rates of recidivism were found among these four groups. However, length of stay did vary, with state funded groups having the shortest length of stay, followed by intensive managed care, traditional managed care, and private payor. The data from this study concluded managed care clients were not more apt to return to treatment as a result of shortened treatment plans. An anecdotal finding was that recidivists had significantly more ICD 9 diagnoses than their counterparts.
While the study by Renz (1995) was narrow in its scope, it does imply that managed care seems effective if one only looks at recidivism as an outcome measure . However, the researchers concluded that recidivism alone was not a sufficient measure of outcome. For example, what happens to the client who relapses but does not return to treatment for any reason?
Other factors that need to be included in outcomes studies are:
• Longitudinal substance abuse patterns.
• Psychosocial adjustment as measured by employment status.
• Family and peer functioning.
• Health and legal status. For example, the issue of employment status was discussed anecdotally by Alexander Consulting Group in Westport, CT (1989) . This study examined the impact of managed care on the Employee Assistance Program at the McDonnell Douglas Helicopter Company. It was found that employees covered by a prepaid arrangement for health care had a job turnover rate three times greater than those covered by a fee for service arrangement. While it is not clear why this occurred, it does demonstrate the need to view issues in addition to recidivism as a means of outcome measure.
BENEFITS FOR SUBSTANCE ABUSE
The concept of "carving out" benefits is relatively new. This arrangement is frequently referred to in the substance abuse treatment literature. Its popularity with the larger health insurers is such that many of them now have a fixed cost for these services. In addition, the risk associated with substance abuse coverages is carved out of the overall health plan and transferred to the benefit vendor or provider.
This method separates the review and handling of substance abuse issues from other health care issues. Typically, a single vendor is chosen to manage, review, and administer this aspect of a health care plan. In some arrangements, the vendor assumes some of the financial risks associated with the cost of this type of program. This system's impact on access and outcome has yet to be definitively demonstrated.
By separating the substance abuse issues, the vendor is presumed to have greater experience in managing this type of need. Therefore , the care a client receives would be more cost effective and efficacious. In addition, by assuming the financial risk, it becomes important for fiscal reasons that the vendor maintains a well population and keeps its clients out of the utilization and cost loop. Garnick (1994) found very few of the firms studied used SEPTEMBER 1997, VOL. 45, NO.9 a separate vendor. However, the researchers did find that most of the firms had nurse reviewers specific to mental health and substance abuse. Thus, a carve out philosophy was created without the inclusion of a third party.
The concept of carving out mental health and substance abuse care from a health plan seems as if it would improve the quality of client care. However, the issue of access and outcome needs as much investigation as with other forms of managed care. The conclusions from the Alexander Consulting Group's (1989) investigation into the impact of carving out mental health and substance abuse benefits at McDonnell Douglas unmistakably demonstrated a significant reduction of costs. However, clinical outcome measures were not reflected. The study did report that the average cost for treatment of substance abuse declined because of reduced per diem payments.
Further, with regard to substance abuse, there was a decrease in use solely as a result of a lower admission rate (down 29%). Lengths of stay remained constant. The lower admission rate was compared to HMO experience from the prior year. When admission rates were compared to the indemnity plan at McDonnell Douglas, the rate was actually higher with the carved out benefit. The carve out rate was 3.0 per 1,000 and the indemnity plan rate 2.0 per 1,000. This would imply that access was improved. However, the study did not identify whether variables other than managed care contributed to this rate. It does imply a correlation of increased access with the use of an effective EAP (Alexander Consulting Group, 1989) .
EMPLOYEE ASSISTANCE PROGRAMS
EAPs have been in existence for some time (Bryant, 1991) . Today EAPs cover substance abuse and psychosocial needs. Historically, EAPs were established to identify employees with alcohol problems affecting job performance. This process facilitated early intervention, consequently restoring job function. Today EAPs deal with a vast array of psychosocial disorders, not only as they relate to the job, but also to the overall well being of the individual. The programs can be internal (i.e., staffed by an employee of the company accepting referrals, conducting assessments, and referring to outside sources as needed) or external (i.e., the program coordinator is subcontracted by the company to provide service, or employees are provided access to a confidential phone number to call for assistance) .
Using EAPs improves client access to the system. Use of EAPs at McDonnell Douglas reduced the cost and increased the effectiveness for employees with substance abuse issues. However, it was unclear if the changes were a function of managed care or of more effective identification of employees with problems (Alexander Consulting Group, 1989) . It can be assumed with early identification and EAP intervention the client has a guide through the system. Easier system access potentiates a positive impact on outcome.
In addition, the EAP can act as a liaison between the benefit provider, treatment provider, and client. However, this can contribute to a conflict of interest.
EAP representatives traditionally serve as advocates for the employee. The EAP must coordinate its interven-
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Mental Health Care Managed Care, Access, and Clinical Outcomes Kelly, J.A. tions with the actions of the managed care representative. The EAP representative may see the need for a client to be admitted to a particular program, while the managed care provider does not view the program as cost effective, agreeing only to an alternative arrangement. This conflict often puts clients in the middle and may actually discourage program participation.
DISCUSSION
Many people with substance abuse issues struggle with their disea se over extended periods of time. Chronicity increases costs for these clients, making them less attractive for types of managed care plans in which the provider assumes some of the financial risk for their care. This arrangement suggests the reduced likelihood of the provider trying a variety of treatment modalities with anyone client in an effort to reduce treatment costs to minimize financial risk. This could be a problem with the rapid growth of carved out benefit designs as these programs are often capitated. Capitated programs require vendors to carefully monitor use of services by each 1. AAOHN Journal, 45(9) : 439-445.
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Mental health and substance abuse problems are rapidly growing components of health care premiums and associated costs.
Managed care has become as integral factor in the delivery of these services. This trend has elicited concerns about the negative impact of managed care on service access and clinical outcomes.
Some managed care designs may actually discourage participation in treatment programs as well as reduce options available to clients. The treatment arena is also shifting from inpatient to outpatient care for most cases.
Studies demonstrate the financial efficacy of managed care. However, insufficient data exist about effects on clinical outcomes.
The addition of an employee assistance program to the managed care process improves access and may positively affect clinical and financial outcomes. client to enhance profitability. Although Wells (1989) found no evidence of ill health effects with capitation, these arrangements need to be measured and analyzed again with the increasing popularity of capitation.
If managed care is, in essence, a policy to substitute outpatient care for inpatient care, questions arise about the outcomes of treatment, as well as both short term and long term cost shifts. Will this type of process curtail service availability, substitute less effective alternative regimens, or actually discourage clients from accessing services as a result of awareness of inadequate coverage or cumbersome approval procedures? The challenge for managed care is to control access without adversely affecting outcome. Further, this process must be cost effective for services to remain accessible. All of this must be accomplished without compromising quality of care. It is not clear whether current managed care methodologies will enhance treatment of mental health or substance abuse issues, or work to their detriment.
The literature implies the concept of managed care can work. However, at the present time, the prime focus is on cost reduction. A critical element missing from the equation is the clinical outcome measurement of the new treatment paradigms. Further research regarding access and clinical outcomes issues needs to be established. Costs can always be reduced. However, occupational health nurses and consumers need be informed about the accessibility and outcomes of available interventions. It is only through this awareness that the overall system can maintain an acceptable level of quality, with high quality remaining the standard.
CONCLUSION
Nurses need to play an active role in helping clients through the maze of managed care. More importantly, nurses need to be actively involved in the development, ongoing evaluation, and provision of substance abuse treatment modalities under managed care. Further analysis can serve to coalesce the fragmented array of studies currently existing on this issue. The knowledge gained through this type of research serves as a catalyst to maintain a quality, cost effective system for treatment of mental health and substance abuse problems.
